Kura Oncology, Inc. (KURA)

Kura Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	95.29	224.46	37.32	51.8	90.67	325.49
Short-Term Investments	454.38	502.93	386.64	386.18	427.29	307.83
Cash & Short-Term Investments	549.67	727.4	423.96	437.99	517.96	633.32
Cash Growth	20.73%	71.57%	-3.20%	-15.44%	-18.21%	167.35%
Other Receivables	-	6.1	1.1	0.9	1.4	-
Receivables	35.94	6.1	1.1	0.9	1.4	-
Prepaid Expenses	35.06	11.33	7.42	7.54	2.93	3.97
Total Current Assets	620.66	744.83	432.48	446.43	522.29	637.29
Property, Plant & Equipment	14.94	7.49	8.85	6.38	8.25	8.36
Other Long-Term Assets	13.78	7.85	7.6	3.5	3.52	1.57
Total Assets	649.38	760.16	448.94	456.31	534.05	647.21
Accounts Payable	4.67	1.47	2.3	1.53	3.24	2.75
Accrued Expenses	62.12	46.42	31.46	20.21	16.96	18.18
Current Portion of Long-Term Debt	4.34	2.61	-	-	-	3
Current Portion of Leases	1.43	1.88	1.51	2.32	2.26	2.09
Current Income Taxes Payable	-	2.06	-	-	-	-
Current Unearned Revenue	48.75	24.27	-	-	-	-
Total Current Liabilities	121.3	78.71	35.26	24.06	22.46	26.02
Long-Term Debt	5.34	6.92	9.33	9.16	-	4.25
Long-Term Leases	8.36	5.19	6.36	2.55	4.61	5.64
Long-Term Unearned Revenue	268.85	253.91	-	-	-	-
Other Long-Term Liabilities	2.98	1.8	0.71	0.27	0.38	0.4
Total Liabilities	406.84	346.52	51.66	36.03	27.44	36.31
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,335	1,308	1,120	997.11	941.36	913.35
Retained Earnings	-1,093	-895.42	-721.44	-568.81	-432.97	-302.5
Comprehensive Income & Other	0.92	0.76	-1.27	-8.03	-1.79	0.05
Shareholders' Equity	242.54	413.64	397.27	420.28	506.61	610.91
Total Liabilities & Equity	649.38	760.16	448.94	456.31	534.05	647.21
Total Debt	19.47	16.59	17.2	14.02	6.88	14.98
Net Cash (Debt)	530.2	710.8	406.76	423.96	511.09	618.34
Net Cash Growth	20.87%	74.75%	-4.06%	-17.05%	-17.35%	169.85%
Net Cash Per Share	6.06	8.25	5.55	6.33	7.70	11.65
Filing Date Shares Outstanding	87.02	80.75	76.14	68.44	66.61	66.21
Total Common Shares Outstanding	87.02	78.23	74.35	68.31	66.57	66.19
Working Capital	499.36	666.12	397.22	422.37	499.83	611.27
Book Value Per Share	2.79	5.29	5.34	6.15	7.61	9.23
Tangible Book Value	242.54	413.64	397.27	420.28	506.61	610.91
Tangible Book Value Per Share	2.79	5.29	5.34	6.15	7.61	9.23
Machinery	3.7	3.21	2.77	2.6	1.99	1.14
Leasehold Improvements	7.56	1.74	1.54	1.54	1.53	1.17

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q